Factors determining long-term success of biologic therapy in rheumatoid arthritis
The necessity to achieve clinical remission or low disease activity in every patient with rheumatoid arthritis highlights the importance of combination therapy with methotrexate and biological agents for treatment of resistant to conventional disease-modifying anti-rheumatic drugs patients. Modern r...
Saved in:
Main Author: | Dmitry Evgenyevich Karateev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2015-09-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/640 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pregnancy Outcumes and Contraceptive Use in Women with Rheumatoid Arthritis: A Comparative Study
by: Lobaba Basim Mohammed Salih, et al.
Published: (2022-12-01) -
EFFICACY OF ETANERCEPT TREATMENT AS A SECOND TNF α INHIBITOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AND PRIMARY AND SECONDARY INEFFICIENCY OR INTOLERANCE OF INFLIXIMAB
by: E. I. Alexeeva, et al.
Published: (2012-11-01) -
Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis
by: B. G. Issayeva, et al.
Published: (2024-10-01) -
THE PROBLEMS OF THE SAFETY OF THERAPY WITH TUMOR NECROSIS FACTOR-а INHIBITORS
by: Dmitry Evgenyevich Karateyev
Published: (2009-09-01) -
How should a patient with rheumatoid arthritis behave after achievement of remission?
by: D. E. Karateev
Published: (2016-03-01)